JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform
Go back to JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform| Arbios Systems, Inc. (NASDAQ: ABOS) | Delayed: 2.41 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.41 | 52 Week High | $0.23 | |||
| Open | $2.41 | 52 Week Low | $0.00 | |||
| Day High | $2.41 | P/E | N/A | |||
| Day Low | $2.41 | EPS | $0.00 | |||
| Volume | 49,845 | |||||
